Halima Elomri
Overview
Explore the profile of Halima Elomri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elsabah H, Ghasoub R, Soliman D, Ibrahim F, Aldapt M, Y Taha R, et al.
Cancer Rep (Hoboken)
. 2024 Jul;
7(7):e2106.
PMID: 38967112
Background: Plasmacytoma of the skull base is a rare manifestation of plasma cell neoplasm with only a few cases documented in literature involving young adults. Plasmacytoma can be an isolated...
2.
Iqbal P, Shahzad A, Shahid Z, Ghori F, Elomri H, Soliman D
Clin Case Rep
. 2023 May;
11(5):e5908.
PMID: 37234472
Chronic myeloid leukemia (CML) is a myeloproliferative disorder due to translocation between chromosomes (9, 22), known as the "Philadelphia chromosome." In 2016, the World health organization (WHO) introduced a new...
3.
Elsabah H, Aldapt M, Taha R, Soliman D, Elomri H, Ibrahim F
Mediterr J Hematol Infect Dis
. 2020 Nov;
12(1):e2020082.
PMID: 33194156
No abstract available.
4.
Abdulla M, Yassin M, Abdelrazek M, Mudawi D, Ibrahim F, Soliman D, et al.
Acta Biomed
. 2018 Feb;
89(2-S):41-46.
PMID: 29451228
Extramedullary hematopoiesis (EMH) is a rare disorder, defined as the appearance of hematopoietic elements outside the bone marrow or peripheral blood. The most common sites of EMH are liver and...
5.
Kassem N, Ismail O, Elomri H, Yassin M
Am J Case Rep
. 2017 Jul;
18:794-798.
PMID: 28706179
BACKGROUND Tyrosine kinase inhibitors (TKIs) are currently an important targeted drug class in the treatment of chronic myeloid leukemia (CML). Imatinib was the first approved TKI for CML in 2001....
6.
Trimeche M, Ziadi S, de Leval L, Hmissa S, Sriha B, Mokni M, et al.
Ann Pathol
. 2005 Sep;
25(2):95-102.
PMID: 16142160
The purpose of this study was to evaluate the prevalence of EBV in non-Hodgkin's lymphomas occuring in non-immunocopromised patients in Tunisia through a series of 126 cases. EBV was investigated...
7.
Skouri H, Bettaieb A, Fromont P, Elomri H, Ennabli S, Bierling P
Eur J Haematol
. 2005 Aug;
75(3):248-51.
PMID: 16104882
We determined the frequency of post-transfusion alloimmunisation against platelet and granulocyte antigens in 51 Tunisian polytransfused patients with haematological diseases. Serum samples were analysed by a standard and an antiglobulin-augmented...
8.
Sendi H, Elghezal H, Temmi H, Hichri H, Gribaa M, Elomri H, et al.
Ann Genet
. 2002 Apr;
45(1):29-32.
PMID: 11934387
This paper presents the results of a cytogenetic analysis in 139 Tunisian patients with de novo acute myeloid leukemia (AML), including 27 children aged 1-15 years and 112 adults. Mean...